leisure time -WSS

leisure time

author：entertainment 2025-09-03 14:39:01 - browse：638

prostate cancer cells — Prostate cancer cells seen under the microscope. NIH

Prostate cancer tends to be the tortoise of tumors, growing and spreading slowly. When cancerous cells escape the golf ball-sized prostate, they can lodge in various places throughout the body. New research shows that where these cells go can affect how long a man survives.

When prostate cancer spreads, or metastasizes, about three-quarters of the time it takes up residence in the bones. Less common locations are the lungs, liver, and lymph nodes.

An international team of researchers pooled information from nine clinical trials to estimate the average survival times for men with prostate cancer that had spread to four different tissues. Metastasis to the lymph nodes was linked to the longest survival; metastasis to the liver led to the shortest.

“This important study confirms that one size does not fit all when it comes to metastatic prostate cancer,” said Dr. Marc Garnick, a prostate cancer specialist at Beth Israel Deaconess Medical Center in Boston.

The new study, led by Susan Halabi, a professor of biostatistics at Duke University School of Medicine, suggests that prostate cancer that skips the bones and spreads to the liver and lungs may represent a different disease than prostate cancer that invades bones or lymph nodes. The results were published Monday in the Journal of Clinical Oncology.

Median survival for metastatic prostate cancer is affected by metastasis site. Mark Dubowski for Duke Health

“A better understanding of how metastatic prostate cancer behaves in different locations is letting us tailor diagnostic approaches and treatments that we hope will improve outcomes,” Garnick said.

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： WHO calls for emergency meeting on new China virus, as cases spread

WSS

As digital health tech proliferates, a new institute aims to cut through hype

Lilly’s weekly insulin works as well as daily products, new studies show

Obesity drug from Roche shows promise in early study

Custom gene therapy hints at new path for rare disease treatments

STAT reporters are Pulitzer Prize finalists for investigative reporting

ALS treatment from Biogen, Ionis fails in study

explore

leisure time

focus

Sports medicine is finally prioritizing gender equality

ARCH Venture Partners tops STAT's 2023 biotech VC rankings

Medical leaders decry Supreme Court decision on affirmative action

Boston hospital trains restaurant workers on naloxone for overdoses

DIEP, the 'gold standard' of breast reconstruction, is under threat

CVS is willing to dump 10% of its Medicare Advantage members

Medical records are filled with copy

Boston hospital trains restaurant workers on naloxone for overdoses

Continuity nursing helped my family in our darkest PICU moments

Hottest summer in 2,000 years puts focus on extreme heat, health

hotspot

Medicare to cover more brain scans for Alzheimer’s patients

In early work, researchers turn to CRISPR to treat Alzheimer's

How dance can help nurses traumatized by Covid

ALS treatment from Biogen, Ionis fails in study

WuXi Biologics beefs up its lobbying operation

Startup Neumora takes a novel depression drug to Phase 3

hotspot

explore

focus

focus